Correlation of clinical and molecular features in spinal bulbar muscular atrophy
Citation Manager Formats
Make Comment
See Comments

Abstract
Objectives: To characterize the clinical and genetic features of spinal bulbar muscular atrophy (SBMA), a rare neurodegenerative disorder caused by the expansion of a CAG repeat in the first exon of the androgen receptor gene, in the United Kingdom.
Methods: We created a national register for SBMA in the United Kingdom and recruited 61 patients between 2005 and 2013. In our cross-sectional study, we assessed, by direct questioning, impairment of activities of daily living (ADL) milestones, functional rating, and subjective disease impact, and performed correlations with both CAG repeat size and degree of somatic mosaicism. Ten patients were deceased, 46 patients participated in the study, and 5 declined.
Results: Subjects had an average age at onset of 43.4 years, and weakness onset most frequently occurred in the lower limbs (87%). Impaired mobility was the most frequently reported problem by patients, followed by bulbar dysfunction. Age distribution of the impairment of ADL milestones showed remarkable overlap with a Japanese study. We have identified a significant correlation between the number of CAG repeats and both age at onset and ADL milestones. Somatic mosaicism also showed a correlation with CAG expansion size and age at onset.
Conclusions: Clinical features in SBMA show a substantial overlap when comparing populations with different genetic backgrounds. This finding has major implications, because multicenter trials will be necessary to obtain sufficient power in future clinical trials. Clinical-genetic correlations are strong in SBMA and should inform any clinical research strategy in this condition.
GLOSSARY
- ADL=
- activities of daily living;
- ALS=
- amyotrophic lateral sclerosis;
- ALSFRS-R=
- revised Amyotrophic Lateral Sclerosis Functional Rating Scale;
- AR=
- androgen receptor;
- MI=
- mosaicism index;
- SBMA=
- spinal bulbar muscular atrophy
Footnotes
↵* These authors contributed equally to this work.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article. The Article Processing Charge was paid by University College London.
Supplemental data at Neurology.org
- Received November 9, 2013.
- Accepted in final form March 10, 2014.
- © 2014 American Academy of Neurology
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Brief Communications
A family with early-onset and rapidly progressive X-linked spinal and bulbar muscular atrophyA. Echaniz-Laguna, E. Rousso, M. Anheim et al.Neurology, April 25, 2005 -
Article
Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessmentsJulia R. Dahlqvist, Sofie T. Oestergaard, Nanna S. Poulsen et al.Neurology, January 04, 2019 -
Articles
Spinobulbar muscular atrophy can mimic ALS: The importance of genetic testing in male patients with atypical ALSJ. S. Parboosingh, D. A. Figlewicz, A. Krizus et al.Neurology, August 01, 1997 -
Article
Biomarker-based analysis of preclinical progression in spinal and bulbar muscular atrophyYasuhiro Hijikata, Atsushi Hashizume, Shinichiro Yamada et al.Neurology, March 23, 2018